TherapeuticsMD (TXMD) Non-Current Receivables (2022 - 2025)
Historic Non-Current Receivables for TherapeuticsMD (TXMD) over the last 4 years, with Q3 2025 value amounting to $14.3 million.
- TherapeuticsMD's Non-Current Receivables fell 1409.39% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.3 million, marking a year-over-year decrease of 1409.39%. This contributed to the annual value of $16.0 million for FY2024, which is 1338.45% down from last year.
- According to the latest figures from Q3 2025, TherapeuticsMD's Non-Current Receivables is $14.3 million, which was down 1409.39% from $14.8 million recorded in Q2 2025.
- Over the past 5 years, TherapeuticsMD's Non-Current Receivables peaked at $20.3 million during Q1 2023, and registered a low of $14.3 million during Q3 2025.
- In the last 4 years, TherapeuticsMD's Non-Current Receivables had a median value of $17.5 million in 2024 and averaged $17.5 million.
- As far as peak fluctuations go, TherapeuticsMD's Non-Current Receivables plummeted by 873.45% in 2023, and later tumbled by 1409.39% in 2025.
- TherapeuticsMD's Non-Current Receivables (Quarter) stood at $20.3 million in 2022, then decreased by 8.73% to $18.5 million in 2023, then decreased by 13.38% to $16.0 million in 2024, then decreased by 10.87% to $14.3 million in 2025.
- Its last three reported values are $14.3 million in Q3 2025, $14.8 million for Q2 2025, and $15.4 million during Q1 2025.